ArticleHead & neck2021

Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer.

William A Stokes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.